Amazon Launches Virtual Health “Storefront”

 

A telehealth solution named Amazon Clinic has been launched by Amazon. Amazon Clinic describes itself as a virtual health “storefront”, where users can search a database of telehealth providers who offer consultations for a wide range of conditions. A total of 32 states will be the first to launch Amazon Clinic. At present, it does not work with health insurance, and prices will vary depending on the provider, condition, and location.

To weigh in on what insurance companies should pay attention to as this solution rolls out, Melanie Musson, Health Insurance Expert at Clearsurance gives her take.

Melanie’s Thoughts:

“Amazon launching their telehealth services is a big deal and insurance companies need to pay attention because the way that insurance is set up is that you pay for a doctor’s visit and whether your problem is minor or major, you’re gonna pay for that office visit and it’s gonna cost probably $150.

And people with high plans, people that don’t expect to meet their deductible, they’re not gonna wanna go to the doctor and spend that much money, but they could use Amazon Telehealth and spend $40 to $60, which is so much cheaper. And they’ll be so much more likely to visit to have a visit with a telehealth doctor or clinician with Amazon.

Insurance companies should probably think about offering similar micro visits for a cheaper cost so that they can compete with what Amazon has.”

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More